Cancer centers have changed the way they deliver care to face challenges brought about by the COVID-19 pandemic, but will these changes stand the test of time?
Recent studies showed associations between quality of life scores and survival in lung and prostate cancer as well as renal cell carcinoma.
Lymphoma patients displayed cognitive decline 6 months after chemotherapy, both by objective assessment and self-report.
The higher contrast of this tool is better than film-screen mammography at detecting calcifications that are key to diagnosing DCIS.
Study reports that a personalized, long-peptide vaccine that can target up to 20 personal neoantigens per patient has been successful in preventing melanoma in patients at high risk for recurrence.
Investigators of the observational study sought to clarify the time-dependent effects between long-term oral contraceptive use and risk for breast, ovarian, and endometrial cancer risk.
The pitfall of self-reported stress levels is that the baseline stress for some people is so high, a cancer diagnosis doesn’t even register.
Preferences are tied not just to the experience of receiving an injection, but also to factors related to a patient’s access to different types of care settings.
Small studies, the absence of subtypes, and a historical lack of genetic information has stopped past studies from triggering meaningful public health change, a review asserts.
Race and ethnicity were key data points collected from the cohort and tracked with outcomes.
